MO
AVNS

McMillan Office’s Avanos Medical AVNS Stock Holding History

McMillan Office’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17K Sell
683
-18
-3% -$421 ﹤0.01% 365
2026
Q1 		$9.82K Sell
701
-149
-18% -$2.01K ﹤0.01% 389
2025
Q4 		$9.55K Buy
+850
New +$9.73K ﹤0.01% 386

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

McMillan Office's AVNS Position: Q2 2026 in Review

McMillan Office reduced its Avanos Medical (AVNS) stake by 2.6% in Q2 2026, selling an estimated $421 and leaving 683 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #365.

McMillan Office first reported a position in AVNS in Q4 2025 and has held it in 3 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • McMillan Office held 683 shares of Avanos Medical worth $17K as of Q2 2026.
  • McMillan Office sold 18 Avanos Medical shares in Q2 2026, an estimated $421.
  • Avanos Medical made up ﹤0.01% of McMillan Office's portfolio in Q2 2026, its #365 holding.
  • McMillan Office first reported a position in Avanos Medical in Q4 2025 and has held it in 3 quarters since.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on McMillan Office's 13F filing for Q2 2026, filed 13 Aug 2026.